Published in Br J Rheumatol on February 01, 1984
Apoptotic Effect of Tolfenamic Acid in KB Human Oral Cancer Cells: Possible Involvement of the p38 MAPK Pathway. J Clin Biochem Nutr (2010) 0.89
Analgesic effect of indomethacin shown using the nociceptive flexion reflex in humans. Ann Rheum Dis (1992) 0.81
Evaluation of the analgesic efficacy and safety of carprofen. Anesth Prog (1991) 0.76
Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group. Lancet (1999) 4.98
Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med (1989) 3.68
Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet (1990) 3.55
The links between joint damage and disability in rheumatoid arthritis. Rheumatology (Oxford) (2000) 3.48
Increased incidence of alcohol-related deaths from accidents and violence in subjects with ankylosing spondylitis. Br J Rheumatol (1998) 2.28
Ten year mortality and causes of death in patients with rheumatoid arthritis. Br Med J (Clin Res Ed) (1985) 2.10
Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment. Br J Rheumatol (1998) 2.02
Effect of gold treatment on the progression of erosions in RA patients. Scand J Rheumatol (1977) 2.01
Cardiovascular mortality in women with rheumatoid arthritis. J Rheumatol (1995) 1.96
Elevated cancer incidence in patients with dermatomyositis: a population based study. J Rheumatol (1995) 1.84
Followup study on patients with Reiter's disease and reactive arthritis, with special reference to HLA-B27. Arthritis Rheum (1982) 1.83
CD4+ CD25+ T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol (2005) 1.76
Death attributed to antirheumatic medication in a nationwide series of 1666 patients with rheumatoid arthritis who have died. J Rheumatol (1995) 1.66
Yersinia specific immune complexes in the synovial fluid of patients with yersinia triggered reactive arthritis. Ann Rheum Dis (1987) 1.63
HLA-DR-DQ haplotypes and genotypes in Finnish patients with rheumatoid arthritis. Ann Rheum Dis (2004) 1.61
Incidence of elbow involvement in rheumatoid arthritis. A 15 year endpoint study. J Rheumatol (2001) 1.56
Prolonged arthritis associated with sindbis-related (Pogosta) virus infection. Rheumatology (Oxford) (2000) 1.52
Prognostic factors and diagnostic criteria in early rheumatoid arthritis. Scand J Rheumatol Suppl (1985) 1.45
Work disability in an inception cohort of patients with seropositive rheumatoid arthritis: a 20 year study. Rheumatology (Oxford) (1999) 1.43
Synovial fluid acid phosphatase in seropositive and seronegative arthritides. Clin Exp Rheumatol (1990) 1.42
Mortality from cancer in patients with rheumatoid arthritis. Scand J Rheumatol (1995) 1.37
Effect of gold on progression of erosions in rheumatoid arthritis. Better results with early treatment. Scand J Rheumatol (1977) 1.35
Genome scan for predisposing loci for distal interphalangeal joint osteoarthritis: evidence for a locus on 2q. Am J Hum Genet (1999) 1.35
Cellular immunohistopathology of acute, subacute, and chronic synovitis in rheumatoid arthritis. Ann Rheum Dis (1985) 1.30
Reactive arthritis after campylobacter jejuni enteritis in patients with HLA-B27. Lancet (1980) 1.29
Arthritis associated with Campylobacter jejuni enteritis. Scand J Rheumatol (1981) 1.27
Shift in the incidence of rheumatoid arthritis toward elderly patients in Finland during 1975-1990. Clin Exp Rheumatol (1997) 1.24
Isolation and characterization of a variety of microcystins from seven strains of the cyanobacterial genus Anabaena. Appl Environ Microbiol (1992) 1.22
Interleukin-10 functions as an antiinflammatory cytokine in rheumatoid synovium. Arthritis Rheum (1996) 1.22
Death rate and causes of death in patients with rheumatoid arthritis. Scand J Rheumatol (1975) 1.20
Finnish case-control and family studies support PTPN22 R620W polymorphism as a risk factor in rheumatoid arthritis, but suggest only minimal or no effect in juvenile idiopathic arthritis. Genes Immun (2005) 1.19
Compliance in psychoses. Acta Psychiatr Scand (1999) 1.19
Elevated incidence of hematologic malignancies in patients with Sjögren's syndrome compared with patients with rheumatoid arthritis (Finland). Cancer Causes Control (1997) 1.18
Prospective meta-analysis of interleukin 1 gene complex polymorphisms confirms associations with ankylosing spondylitis. Ann Rheum Dis (2007) 1.18
Sulfasalazine in the treatment of ankylosing spondylitis. A twenty-six-week, placebo-controlled clinical trial. Arthritis Rheum (1988) 1.18
Testing of variants of the MTHFR and ESR1 genes in 1798 Finnish individuals fails to confirm the association with migraine with aura. Cephalalgia (2006) 1.16
Intestinal flora in early rheumatoid arthritis. Br J Rheumatol (1994) 1.16
Periarticular corticosteroid treatment of the sacroiliac joint in patients with seronegative spondylarthropathy. Clin Exp Rheumatol (1999) 1.15
Cerebral vasculitis visualized by angiography in juvenile rheumatoid arthritis simulating brain tumor. Acta Rheumatol Scand (1968) 1.13
Causes of death in autopsied RA patients. Scand J Rheumatol (1976) 1.13
Shortening of life span and causes of excess mortality in a population-based series of subjects with rheumatoid arthritis. Clin Exp Rheumatol (1995) 1.13
Splenomegaly in rheumatoid arthritis. Acta Rheumatol Scand (1971) 1.12
Cardiovascular mortality in patients with rheumatoid arthritis. Cardiology (1989) 1.12
HLA-D antigens in rheumatoid arthritis and toxicity to gold and penicillamine. Scand J Rheumatol (1986) 1.12
Persistence of Yersinia antigens in peripheral blood cells from patients with Yersinia enterocolitica O:3 infection with or without reactive arthritis. Arthritis Rheum (1998) 1.12
Prognosis of inflammatory joint diseases. A three-year follow-up study. Scand J Rheumatol (1983) 1.11
Antifilaggrin antibodies in recent-onset arthritis. Scand J Rheumatol (1999) 1.11
Detection of herpesviruses by polymerase chain reaction in lymphocytes from patients with rheumatoid arthritis. Arthritis Rheum (1993) 1.10
Incidence of rheumatoid arthritis in Finland during 1980-1990. Ann Rheum Dis (1996) 1.10
Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis--a pilot study. Scand J Rheumatol (2003) 1.09
Death rate and causes of death in RA patients during a period of five years. Scand J Rheumatol (1977) 1.09
Combination drug therapy retards the development of rheumatoid atlantoaxial subluxations. Arthritis Rheum (2000) 1.09
Effect of antimicrobial treatment on chronic reactive arthritis. Clin Exp Rheumatol (1993) 1.08
Hip joint ultrasonography: correlation with intra-articular effusion and synovitis. Br J Rheumatol (1990) 1.07
Sindbis viruses and other alphaviruses as cause of human arthritic disease. J Intern Med (2004) 1.07
Fibronectin in synovial fluid and tissue in rheumatoid arthritis. Eur J Clin Invest (1981) 1.07
[Rheumatoid arthritis shortens life]. Duodecim (1995) 1.07
Finnish HLA studies confirm the increased risk conferred by HLA-B27 homozygosity in ankylosing spondylitis. Ann Rheum Dis (2005) 1.05
The prediction of radiological destruction during the early stage of rheumatoid arthritis. Clin Exp Rheumatol (1985) 1.05
Does parvovirus B19 have a role in rheumatoid arthritis? Ann Rheum Dis (1994) 1.03
Dry beriberi in a slimmer. Br Med J (1978) 1.03
Subacromial space in the rheumatoid shoulder: a radiographic 15-year follow-up study of 148 shoulders. J Shoulder Elbow Surg (2000) 1.02
Clinical arthritis associated with positive radiological and serological findings in Finnish adults. Rheumatol Int (1989) 1.02
Correlation between mobility restrictions and radiologic changes in ankylosing spondylitis. Spine (Phila Pa 1976) (1995) 1.02
Yersinia enterocolitica activates a T helper type 1-like T cell subset in reactive arthritis. J Immunol (1992) 1.02
The presence of interleukin-13 in rheumatoid synovium and its antiinflammatory effects on synovial fluid macrophages from patients with rheumatoid arthritis. Arthritis Rheum (1996) 1.02
Conventional monotherapy compared to a "sawtooth" treatment strategy in the radiographic progression of rheumatoid arthritis over the first eight years. Clin Exp Rheumatol (1999) 1.01
Rise in serum C reactive protein after hip and knee arthroplasties in patients with rheumatoid arthritis. Ann Rheum Dis (2001) 1.01
HLA haplotype analysis in Finnish patients with rheumatoid arthritis. Arthritis Rheum (2001) 1.01
A simple enzyme immunoassay for the demonstration of rheumatoid factor. J Immunol Methods (1979) 1.01
Prevalence of radiological changes in the cervical spine--a cross sectional study after 20 years from presentation of rheumatoid arthritis. J Rheumatol (2000) 1.01
Levamisole and agranulocytosis. Lancet (1976) 1.00
Comparison of chemical, radiation and surgical synovectomy for knee joint synovitis. Scand J Rheumatol (1978) 0.99
Need and sequence of large joint replacements in rheumatoid arthritis. A 25-year follow-up study. Clin Exp Rheumatol (2002) 0.98
Bacterial antibodies in ankylosing spondylitis. Clin Exp Immunol (1991) 0.98
Death certificate and mortality in rheumatoid arthritis. Scand J Rheumatol (1986) 0.98
Monetary value of lost productivity over a five year follow up in early rheumatoid arthritis estimated on the basis of official register data on patients' sickness absence and gross income: experience from the FIN-RACo trial. Ann Rheum Dis (2005) 0.97
Prospect for an additional laboratory criterion for rheumatoid arthritis. Scand J Rheumatol (1993) 0.97